MedTrace Logo

Clinical Trials

NCT05327608 | RECRUITING | PHASE2
55 participants

Neoadjuvant Breast Cancer Time Restricted Eating

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-07-28
Completion:
2027-05-01
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Breast Ductal Carcinoma in Situ
  • HER2 Negative Breast Carcinoma
  • Hormone Receptor Positive Breast Carcinoma
  • Invasive Breast Carcinoma
Interventions
  • OTHER
No Results Yet
NCT05232825 | COMPLETED | PHASE3
236 participants

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-05-03
Completion:
2023-03-10
Conditions
  • Relapsing Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
Interventions
  • DRUG
Results Available
NCT05201534 | RECRUITING | NA
180 participants

Interventions in Mathematics and Cognitive Skills

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-05-05
Completion:
2027-08-31
Conditions
  • Math Learning Disability
  • Child Development
  • Developmental Disability
  • Learning Disabilities
  • Learning Disabled
  • Learning Curve
  • Mathematics Disorder
  • Dyscalculia
  • Dyscalculia, Primary
  • Dyscalculia, Acquired
  • Specific Learning Disorder, With Impairment in Mathematics
  • Individuality
  • Behavior, Child
  • Behavior and Behavior Mechanisms
  • Behavior
  • Decision Making
  • Neuronal Plasticity
  • Cognition
  • Cognition Disorder
  • Cognitive Dysfunction
  • Cognitive Change
  • Cognitive Impairment, Mild
  • Cognitive Developmental Delay
  • Cognitive Orientation
  • Cognitive Delay, Mild
  • Cognitive Deficits, Mild
  • Cognitive Abnormality
  • Neuroscience
Interventions
  • OTHER
No Results Yet
NCT05101213 | TERMINATED | PHASE1
12 participants

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-01-06
Completion:
2026-08-03
Conditions
  • Adenovirus Infection
  • BK Virus Infection
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid Cell Neoplasm
  • JC Virus Infection
  • Malignant Solid Neoplasm
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions
  • BIOLOGICAL
No Results Yet
NCT05091957 | RECRUITING | NA
80 participants

Connecting Families

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-05-17
Completion:
2027-04-30
Conditions
  • Poverty
  • Primary Care
  • Intervention
Interventions
  • OTHER
No Results Yet
NCT05050214 | COMPLETED | PHASE2
20 participants

Obinutuzumab in Primary MN

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-02-18
Completion:
2026-03-12
Conditions
  • Membranous Nephropathy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page